For An Appointment
Lipidology is the evaluation and management of cholesterol disorders and metabolism. The evaluation for risk assessment for heart attack and stroke risk is complex. This subspecialty has been "born" out of the need to have focused in-depth knowledge of the established as well as ongoing emerging information and testing techniques related to cholesterol disorders and heart attack risk. Dr. Kordonowy is a member of the National Lipid Association and it's regional chapter known as the Southeast Lipid Association. He is also a member of the Florida Lipid Foundation, now the Foundation of the National Lipid Association. The foundation is solely an academic body whose mission is to educate other clinicians as it relates to Lipidology. He is one of only a few hundred certified Lipidologists in the country. The area of lipidology includes the assessment and management of obesity and metabolic syndrome, which has become an epidemic in the United States.
As a Lipidologist, Dr. Kordonowy has stated a goal of providing a very unique, rare but potentially life saving service known as LDL apheresis to the Lee County population. LDL apheresis is a 2 times monthly "dialysis" of cholesterol from the blood. It is indicated for the rare condition of Familial Hyercholesterolemia and also for patients with established vascular disease who can't get to treatment goals using medications and diet. As part of Dr. Kordonowy's comprehensive lipid management approach he has arranged for on-site certified dietitian, Marcy Russo, to assist in dietary and behavior modification to reduce cardiovascular risk.
For lecture or health prevention consultation please contact Linda Hiscock, Practice Administrator at 275-0040 ext 206.
Advanced Lipid Testing
Elevated cholesterol (especially LDL cholesterol) is associated with increased risk for heart attack and stroke. Presently the National Cholesterol Education Program (NCEP) guidelines call for physician's and patients to measure serum cholesterol levels to screen for elevated cholesterol. Depending upon other risk factors such as age, sex, presence of high blood pressure or diabetes, the NCEP guidelines recommend goals for LDL to improve risk of heart attack and stroke. Cholesterol as measured in traditional blood testing is actually a "step" away from the true disorder which is lipoprotein abnormalities. Lipoproteins are spheres containing cholesterol and triglycerides with proteins attached to the surface of the spheres.
There are now commercially available tests which look "deeper" into a patients blood to assess these lipoproteins-allowing a "truer" picture of cardiovascular risk. Additionally, there are certain identifiable non-cholesterol risk factors that can also be measured to get additional information about an individual's risk for heart attack. IMSWF clinicians are familiar with these various tests. In certain individuals it may be very helpful in assisting patients in deciding if they truly will benefit from recommended therapies. Often persons who appear to be at average risk based upon measured cholesterol are in fact at significantly higher risk. Conversely, sometimes persons who meet recommended guidelines for treatment may be at lower risk than the traditional cholesterol assay suggests.
Tests that can be ordered include: Profile assays such as the Berkeley Heartlab test; the Lipomed NMR assay; LLP by Spectracell; and the VAP profile.
The clinician's at IMSWF are familiar with interpretation of any of these assays. If you feel you may benefit from such testing please discuss this with your physician, or submit a request form.
Learn more about dietary counseling offered at our practice.